Switch to:
More From Other Websites
IBD 50 Stocks Setting Up, Including These 5 Medicals Sep 19 2014
SNN, ALXN And ACT, 3 Health Care Stocks Pushing The Sector Lower Sep 17 2014
ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Sep 17 2014
Alexion Strengthens and Broadens Its Executive Leadership Team Sep 17 2014
Roche's $8 billion InterMune buy not a signal for more big deals Sep 16 2014
Nasdaq Falls Hard, But Apple Resilient On iPhone Orders Sep 15 2014
Improved Survival Observed in Pediatric Patients with Severe Hypophosphatasia (HPP) Who Were Treated... Sep 14 2014
Gilead, Jazz, Salix Among Top 6 IBD 50 Drugmakers Sep 13 2014
Short Sellers Remain Vigilant Against Biotechs Sep 11 2014
Stocks Turn Higher After Soft Start; U.S. Silica Jumps Sep 10 2014
Alexion's Asfotase Alfa Gets Japanese Orphan Drug Status Sep 09 2014
SunTrust Robinson Humphrey Starts Coverage on 5 Top Biotech Stocks Sep 08 2014
Asfotase Alfa Granted Orphan Drug Designation in Japan Sep 08 2014
Asfotase Alfa Granted Orphan Drug Designation in Japan Sep 08 2014
Alexion Pharmaceuticals: FDA Findings An Easy Fix Sep 05 2014
Insider Trading Alert - BRCM, ALXN And JLL Traded By Insiders Sep 05 2014
Alexion Pharmaceuticals' Soliris Wins NICE Backing for aHUS Sep 04 2014
UK watchdog backs Alexion's "very expensive" drug Sep 03 2014
NICE Recommends Commissioning of Eculizumab (Soliris®) for All Patients with aHUS in England Sep 03 2014
Insider Trading Alert - TKR, MTOR And ALXN Traded By Insiders Sep 02 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK